Sonoma Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Revenue	16.94	14.29	12.74	13.27	12.63	18.63	Upgrade
Revenue Growth (YoY)	25.02%	12.20%	-4.05%	5.10%	-32.21%	3.91%	Upgrade
Cost of Revenue	10.56	8.82	7.99	8.8	8.64	12.07	Upgrade
Gross Profit	6.38	5.47	4.75	4.48	3.99	6.56	Upgrade
Selling, General & Admin	7.49	7.36	7.58	8.84	9.76	9.45	Upgrade
Research & Development	2.01	1.81	1.87	0.21	0.13	0.56	Upgrade
Operating Expenses	9.5	9.18	9.45	9.05	9.88	10.01	Upgrade
Operating Income	-3.12	-3.71	-4.7	-4.57	-5.89	-3.45	Upgrade
Interest Expense	-	-	-	-	-0.01	-	Upgrade
Interest & Investment Income	-	-	-	-	-	0	Upgrade
Currency Exchange Gain (Loss)	0.24	0.24	-0.83	-0.69	-0.58	-0.69	Upgrade
Other Non Operating Income (Expenses)	-0.54	0.56	0.5	0.08	0.19	0.1	Upgrade
EBT Excluding Unusual Items	-3.42	-2.91	-5.03	-5.18	-6.29	-4.04	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	0.15	0.14	Upgrade
Other Unusual Items	-	-	-	-	0.72	-	Upgrade
Pretax Income	-3.42	-2.91	-5.03	-5.18	-5.42	-3.9	Upgrade
Income Tax Expense	0.06	0.55	-0.2	-0.03	-0.33	0.71	Upgrade
Earnings From Continuing Operations	-3.48	-3.46	-4.84	-5.15	-5.09	-4.62	Upgrade
Earnings From Discontinued Operations	-	-	-	-	-	0.67	Upgrade
Net Income	-3.48	-3.46	-4.84	-5.15	-5.09	-3.95	Upgrade
Net Income to Common	-3.48	-3.46	-4.84	-5.15	-5.09	-3.95	Upgrade
Shares Outstanding (Basic)	2	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	2	1	0	0	0	0	Upgrade
Shares Change (YoY)	98.88%	172.75%	168.12%	27.93%	32.92%	35.14%	Upgrade
EPS (Basic)	-2.19	-2.79	-10.63	-30.35	-38.34	-39.58	Upgrade
EPS (Diluted)	-2.19	-2.79	-10.63	-30.35	-38.34	-39.58	Upgrade
Free Cash Flow	-2.35	-0.17	-2.4	-6.42	-4.39	-3.56	Upgrade
Free Cash Flow Per Share	-1.47	-0.14	-5.28	-37.84	-33.06	-35.64	Upgrade
Gross Margin	37.68%	38.25%	37.26%	33.73%	31.62%	35.21%	Upgrade
Operating Margin	-18.41%	-25.97%	-36.91%	-34.43%	-46.62%	-18.51%	Upgrade
Profit Margin	-20.54%	-24.20%	-37.97%	-38.81%	-40.28%	-21.20%	Upgrade
Free Cash Flow Margin	-13.84%	-1.18%	-18.85%	-48.38%	-34.72%	-19.09%	Upgrade
EBITDA	-2.98	-3.57	-4.53	-4.45	-5.7	-3.22	Upgrade
EBITDA Margin	-17.61%	-25.00%	-35.53%	-33.49%	-45.15%	-17.30%	Upgrade
D&A For EBITDA	0.14	0.14	0.18	0.13	0.19	0.23	Upgrade
EBIT	-3.12	-3.71	-4.7	-4.57	-5.89	-3.45	Upgrade
EBIT Margin	-18.41%	-25.97%	-36.91%	-34.43%	-46.62%	-18.51%	Upgrade
Advertising Expenses	-	0.19	0.16	0.16	0.09	0.04	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q